BDSX logo

Biodesix (BDSX) Cash From Financing

Annual CFF

$29.13 M
-$29.75 M-50.53%

31 December 2023

BDSX Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFF

$144.00 K
-$51.15 M-99.72%

30 September 2024

BDSX Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFF

$73.96 M
-$12.01 M-13.97%

30 September 2024

BDSX TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BDSX Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-50.5%-98.8%+50.2%
3 y3 years-64.1%-63.6%+4.6%
5 y5 years+53.0%--

BDSX Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-64.1%+2208.2%-99.7%+103.3%-14.0%+1233.8%
5 y5 years-64.1%+2208.2%-99.8%+103.3%-14.0%+1233.8%
alltimeall time-64.1%+2208.2%-99.8%+103.3%-14.0%+1233.8%

Biodesix Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
$144.00 K(-99.7%)
$73.96 M(-14.0%)
June 2024
-
$51.30 M(+6385.0%)
$85.97 M(+165.8%)
Mar 2024
-
$791.00 K(-96.4%)
$32.34 M(+11.0%)
Dec 2023
$29.13 M(-50.5%)
$21.73 M(+78.8%)
$29.13 M(-40.9%)
Sept 2023
-
$12.15 M(-621.5%)
$49.25 M(+41.4%)
June 2023
-
-$2.33 M(-3.8%)
$34.83 M(-41.3%)
Mar 2023
-
-$2.42 M(-105.8%)
$59.30 M(+0.7%)
Dec 2022
$58.88 M
$41.85 M(-1947.6%)
$58.88 M(+364.7%)
Sept 2022
-
-$2.27 M(-110.2%)
$12.67 M(-17.4%)
June 2022
-
$22.13 M(-881.0%)
$15.33 M(-335.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$2.83 M(-35.0%)
-$6.52 M(-616.9%)
Dec 2021
$1.26 M(-98.4%)
-$4.36 M(-1201.8%)
$1.26 M(-98.2%)
Sept 2021
-
$396.00 K(+42.4%)
$70.70 M(+0.6%)
June 2021
-
$278.00 K(-94.4%)
$70.31 M(-11.7%)
Mar 2021
-
$4.95 M(-92.4%)
$79.66 M(-1.8%)
Dec 2020
$81.13 M(+253.2%)
$65.08 M(>+9900.0%)
$81.13 M(+405.3%)
Sept 2020
-
$9000.00(-99.9%)
$16.05 M(+0.1%)
June 2020
-
$9.63 M(+49.9%)
$16.05 M(+149.9%)
Mar 2020
-
$6.42 M
$6.42 M
Dec 2019
$22.97 M(+20.7%)
-
-
Dec 2018
$19.03 M
-
-

FAQ

  • What is Biodesix annual cash flow from financing activities?
  • What is the all time high annual CFF for Biodesix?
  • What is Biodesix annual CFF year-on-year change?
  • What is Biodesix quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Biodesix?
  • What is Biodesix quarterly CFF year-on-year change?
  • What is Biodesix TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Biodesix?
  • What is Biodesix TTM CFF year-on-year change?

What is Biodesix annual cash flow from financing activities?

The current annual CFF of BDSX is $29.13 M

What is the all time high annual CFF for Biodesix?

Biodesix all-time high annual cash flow from financing activities is $81.13 M

What is Biodesix annual CFF year-on-year change?

Over the past year, BDSX annual cash flow from financing activities has changed by -$29.75 M (-50.53%)

What is Biodesix quarterly cash flow from financing activities?

The current quarterly CFF of BDSX is $144.00 K

What is the all time high quarterly CFF for Biodesix?

Biodesix all-time high quarterly cash flow from financing activities is $65.08 M

What is Biodesix quarterly CFF year-on-year change?

Over the past year, BDSX quarterly cash flow from financing activities has changed by -$12.01 M (-98.82%)

What is Biodesix TTM cash flow from financing activities?

The current TTM CFF of BDSX is $73.96 M

What is the all time high TTM CFF for Biodesix?

Biodesix all-time high TTM cash flow from financing activities is $85.97 M

What is Biodesix TTM CFF year-on-year change?

Over the past year, BDSX TTM cash flow from financing activities has changed by +$24.71 M (+50.17%)